NASDAQ · GANX
Gain Therapeutics, Inc.
Healthcare · Biotechnology
$1.67
Up+$0.00 (+0.00%)
Updated Oct 7, 2026, 10:01 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 148.53M
- P/E ratio
- -6.72
- Dividend yield
- 0.00%
- 52-week range
- $1.53 – $3.07
- Volume
- 646.56K
- Avg. volume
- 1.01M
Price performance · GANX
GANX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
GANX closed at $1.67 after 21 trading sessions, down 8.74% for the selected period.
- Last close
- $1.67
- Period change
- -8.74%
- Period low
- $1.67
- Period high
- $1.95
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $1.70 | $1.75 | $1.655 | $1.67 | 646.56K |
| Oct 5, 2026 | $1.75 | $1.77 | $1.69 | $1.69 | 351.04K |
| Oct 2, 2026 | $1.75 | $1.78 | $1.70 | $1.71 | 386.09K |
| Oct 1, 2026 | $1.725 | $1.7734 | $1.67 | $1.72 | 497.41K |
| Sep 30, 2026 | $1.70 | $1.8399 | $1.69 | $1.73 | 787.97K |
| Sep 29, 2026 | $1.75 | $1.76 | $1.60 | $1.68 | 1.29M |
| Sep 28, 2026 | $1.75 | $1.82 | $1.72 | $1.77 | 548.02K |
| Sep 25, 2026 | $1.85 | $1.8827 | $1.775 | $1.78 | 383.02K |
| Sep 24, 2026 | $1.84 | $1.855 | $1.79 | $1.84 | 407.68K |
| Sep 23, 2026 | $1.91 | $1.9733 | $1.83 | $1.84 | 292.88K |
| Sep 22, 2026 | $1.85 | $1.96 | $1.825 | $1.95 | 692.7K |
| Sep 21, 2026 | $1.80 | $1.85 | $1.7799 | $1.84 | 335.86K |
| Sep 18, 2026 | $1.79 | $1.805 | $1.75 | $1.76 | 375.55K |
| Sep 17, 2026 | $1.77 | $1.785 | $1.735 | $1.78 | 341.54K |
| Sep 16, 2026 | $1.73 | $1.7895 | $1.70 | $1.72 | 265.93K |
| Sep 15, 2026 | $1.74 | $1.74 | $1.69 | $1.71 | 215.69K |
| Sep 14, 2026 | $1.76 | $1.80 | $1.73 | $1.74 | 360.12K |
| Sep 11, 2026 | $1.748 | $1.78 | $1.72 | $1.75 | 223.56K |
| Sep 10, 2026 | $1.72 | $1.74 | $1.69 | $1.71 | 505.65K |
| Sep 9, 2026 | $1.81 | $1.83 | $1.72 | $1.72 | 513.39K |
| Sep 8, 2026 | $1.80 | $1.85 | $1.77 | $1.83 | 292.34K |
Latest GANX news
The latest Smart Investors Daily articles mentioning GANX.
Stock researchResearch & News · News
Company
Market Activity
Research & News

